Order Article Reprints

Gheorghe AS, Chirea IA, Margan MM, Georgescu M-T, Komporaly IA, Kajanto LA, Iovănescu EA, Georgescu B, Matei R, Zob DL, et al. Enhancing Prognosis in Advanced Ovarian Cancer: Primary Cytoreductive Surgery and Adjuvant Chemotherapy or Neoadjuvant Chemotherapy and Interval Cytoreduction—A Single-Center Retrospective Observational Study. Cancers. 2025; 17(8):1314. https://doi.org/10.3390/cancers17081314

Gheorghe, Adelina Silvana, Irina Alexandra Chirea, Mădălin Marius Margan, Mihai-Teodor Georgescu, Isabela Anda Komporaly, Lidia Anca Kajanto, Elena Adriana Iovănescu, Bogdan Georgescu, Radu Matei, Daniela Luminița Zob, and et al. 2025. "Enhancing Prognosis in Advanced Ovarian Cancer: Primary Cytoreductive Surgery and Adjuvant Chemotherapy or Neoadjuvant Chemotherapy and Interval Cytoreduction—A Single-Center Retrospective Observational Study" Cancers 17, no. 8: 1314. https://doi.org/10.3390/cancers17081314

Gheorghe, A. S., Chirea, I. A., Margan, M. M., Georgescu, M.-T., Komporaly, I. A., Kajanto, L. A., Iovănescu, E. A., Georgescu, B., Matei, R., Zob, D. L., Mardare, M., Ginghină, O., Mihai, M. M., & Stănculeanu, D. L. (2025). Enhancing Prognosis in Advanced Ovarian Cancer: Primary Cytoreductive Surgery and Adjuvant Chemotherapy or Neoadjuvant Chemotherapy and Interval Cytoreduction—A Single-Center Retrospective Observational Study. Cancers, 17(8), 1314. https://doi.org/10.3390/cancers17081314